Trademarkia Logo

Canada

C$
Trademark Search in Canada
NEFSPARRI

View On IC.GC.CA

NEFSPARRI
CANCELLED

Last Applicant/ Owned by

Travere Therapeutics, Inc.

3611 Valley Centre Drive, Suite 300San Diego CA 92130

US

Serial Number

2202068 filed on 27th Jun 2022

Registration Number

TMA1224639 registered on 7th Mar 2024

Registration expiry Date

27th Jun 2032

NEFSPARRI

Trademark usage description

pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis ( Read More

Classification Information

Class [005]
Pharmaceutical preparations for the treatment of kidney disease; pharmaceutical preparations for the treatment of focal segmental glomerulosclerosis (FSGS); pharmaceutical preparations for the treatment of Immunoglobulin A Nephropathy (IgAN); pharmaceutical preparations for the treatment of Alport Syndrome; pharmaceutical preparations for the treatment of glomerulonephropathy; pharmaceutical preparations for the treatment of glomerulonephritis.

Classification kind code

11

Mark Details

Serial Number

2202068

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 20th Dec 2023		Advertised
Submitted for opposition 26
on 24th Nov 2023		Approved
Submitted for opposition 27
on 24th Nov 2023		Approval Notice Sent
Submitted for opposition 22
on 20th Nov 2023		Search Recorded
Submitted for opposition 256
on 5th Jun 2023		Notification of Possible Opposition Sent
Submitted for opposition 257
on 4th Aug 2022		Designation Notification - Madrid Protocol
Submitted for opposition 1
on 3rd Aug 2022		Created
Submitted for opposition 31
on 3rd Aug 2022		Formalized
Submitted for opposition 228
on 27th Jun 2022		International Registration
Submitted for opposition 30
on 27th Jun 2022		Filed